Poison Oak Contact Dermatitis Treatment
Covered by Aetna in California

Prednisone 40–60 mg daily for 3–5 days, then taper by 5–10 mg every 2–3 days over a total 14-to-21-day course for moderate-to-severe poison oak/ivy rash; a shorter Medrol Dose Pack (6-day course) is specifically NOT recommended — it is too brief and commonly causes rebound dermatitis within days of completing the pack; full 2–3-week taper is the standard of care

Triamcinolone 0.1% cream topically twice daily for limited, localized rash (< 5% body surface area) without facial or genital involvement; hydroxyzine 25–50 mg at bedtime for nocturnal itch; diphenhydramine 25–50 mg PRN for itch and sleep; oral antihistamines reduce itch through sedation but do not meaningfully reduce the type IV hypersensitivity reaction — prednisone is the mechanistically appropriate treatment for severe inflammation

Yes — prednisone generic is Tier 1, typically $4–$15 for a 3-week course. Triamcinolone cream generic is Tier 1, typically $5–$15. Hydroxyzine generic is Tier 1. No PA required for these generics for contact dermatitis.

Urushiol-induced contact dermatitis is a classic delayed-type (Type IV) hypersensitivity reaction — antihistamines do not block the cell-mediated immune response and should not be relied upon as primary therapy. The rash does not spread from scratching or blister fluid — delayed appearance of new lesions reflects areas of lower initial urushiol exposure and different kinetics of immune response development, not spreading. Calamine lotion and colloidal oatmeal baths provide symptomatic relief. Rash involving greater than 25% BSA, eyelids, genitalia, or with inhalation exposure (from burning poison oak — a specific risk for CalFire and wildland fire workers) warrants urgent in-person evaluation.

Yes — for the vast majority of Californians, the urushiol-producing plant you encounter outdoors is Pacific poison oak (Toxicodendron diversilobum), not poison ivy. Poison ivy (T. radicans) is common in the eastern US but is not a significant presence in California's wild or urban green spaces. Pacific poison oak grows as a shrub or low vine throughout California's coastal ranges, Sierra foothills, and chaparral zones. The clinical presentation of the rash is identical regardless of which plant caused it — both produce urushiol — but if you're a California resident or visitor who had a rash after hiking or gardening, you were almost certainly exposed to poison oak.

A Medrol Dose Pack (methylprednisolone 4 mg tapered over 6 days) is widely recognized as too short for moderate-to-severe urushiol contact dermatitis and frequently causes a rebound flare after the pack is finished. Standard clinical practice — supported by dermatologists and family medicine guidelines — calls for a 14-to-21-day prednisone taper, beginning at 40–60 mg daily and reducing slowly. Stopping oral steroids too soon allows the ongoing immune reaction to reassert fully. Dr. Bhavsar prescribes the appropriately dosed and tapered prednisone course, not the abbreviated Dose Pack. If you've experienced a rebound after a short steroid course, a longer taper at your follow-up visit is appropriate.

Mild periorbital (around the eye) involvement with swelling and rash — where the eye itself is unaffected and you can open both eyes — can be managed with an oral prednisone taper prescribed via telehealth. However, if your eyelids are swollen shut, you have eye pain, blurred vision, or the rash is inside the eye, you need urgent in-person ophthalmology evaluation. Significant facial edema from poison oak can occasionally impair the airway — if you notice throat swelling, difficulty swallowing, or hoarseness in addition to your facial rash, that is an emergency requiring 911 or an ER visit. Dr. Bhavsar will assess facial and ocular involvement during your video visit and will direct you in-person if the severity warrants it.

With appropriate oral prednisone (40–60 mg daily, tapered over 14–21 days), most moderate-to-severe poison oak rashes show significant improvement within 2–4 days of starting treatment and largely resolve by the end of the taper. Without treatment, a severe urushiol reaction can persist for 2–5 weeks. Even with prednisone, new lesion areas may continue appearing for 3–7 days after first exposure as areas with less initial urushiol exposure reach their immune threshold — this is not a sign of spreading or treatment failure. The rash is not contagious after the urushiol oil has been washed off the skin — blisters and seeping fluid do not spread the rash to others.

Yes. Aetna commercial plans cover telehealth visits for Poison Oak Contact Dermatitis in California. TeleDirectMD (Dr. Parth Bhavsar, MD, NPI: 1104323203) is an in-network telehealth provider with Aetna in California. Your standard Aetna telehealth copay applies — typically $10–$40 for most commercial plans. If clinically appropriate, your prescription is sent to your California pharmacy immediately after your visit.

Most Aetna commercial plans in California have telehealth copays of $10–$40. Often $0–$20 for employer plans. Your exact cost depends on your specific plan and whether your deductible has been met. Log into your Aetna member portal or call the member services number on your card to verify your telehealth copay before your poison oak / ivy treatment visit. Self-pay is always available for a flat $49 if you prefer to skip insurance.

If your specific Aetna plan is not in-network with TeleDirectMD in California, or if your deductible has not yet been met, you can book as a self-pay patient for a flat $49 fee — same physician, same quality of care, no insurance needed. You may also be eligible to submit an out-of-network claim to Aetna for partial reimbursement depending on your plan's out-of-network benefit.

TeleDirectMD typically offers same-day and next-day video visits. Book at teledirectmd.com/book-online and select a time that works for you. Most patients are seen within a few hours of booking during business hours. Your poison oak / ivy treatment symptoms are evaluated by Dr. Bhavsar, MD — not a nurse practitioner or PA — ensuring you receive a board-certified clinical assessment.

Yes. TeleDirectMD is operated by Dr. Parth Bhavsar, MD (NPI: 1104323203), a board-certified Family Medicine physician. TeleDirectMD is LegitScript certified, HIPAA compliant, and is contracted as an in-network telehealth provider with Aetna in California. Claims are billed using standard CPT codes (99213/99214) and submitted electronically to Aetna.

Yes. Telehealth visits with a licensed physician are qualified medical expenses eligible for FSA (Flexible Spending Account) and HSA (Health Savings Account) payment. If your Aetna plan applies your deductible first, your FSA or HSA card can be used to pay your portion. The $49 self-pay option is also FSA/HSA eligible.